Kinin B2 receptor-mediated contraction of tail arteries from normal or streptozotocin-induced diabetic rats

British Journal of Pharmacology

Volumn 125, Issue 1, 1998, Pages 143-151

  Wang, Zunzhe ^a   Wu, Lingyun ^b   Wang, Rui ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bradykinin; Contraction; Diabetes; Smooth muscle; Tail artery

Indexed keywords

BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR AGONIST; CALCIUM ION; ICATIBANT; INDOMETACIN; THAPSIGARGIN; BRADYKININ RECEPTOR; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY TONE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; EXTRACELLULAR CALCIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; STREPTOZOCIN DIABETES; TAIL ARTERY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; ANIMAL; ARTERY; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TAIL; VASCULARIZATION; VASOCONSTRICTION;

ANIMALS; ARTERIES; BRADYKININ; DIABETES MELLITUS, EXPERIMENTAL; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; STREPTOZOCIN; TAIL; VASOCONSTRICTION;

EID: 0031595264     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702017     Document Type: Article

References (39)

1. BANERJEE, A., ROMAN, C. & HEYMANN, M.A. (1994). Bradykinin receptor blockade does not affect oxygen-mediated pulmonary vasodilation in fetal lambs. Pediatr. Res., 36, 474-480.
2. BOUTHILLIER, J., DEBLOIS, D. & MARCEAU, F. (1987). Studies on the induction of pharmacological responses to des-Arg9-bradykinin in vitro and in vivo. Br. J. Pharmacol., 92, 257-264.
3. BURCH, R.M., FARMER, S.G. & STERANKA, L.R. (1990). Bradykinin receptor antagonists. Med. Res. Rev., 10, 237-269.
4. CALIXTO, J.B. & MEDEIROS, Y.S. (1992). Effect of protein kinase C and calcium on bradykinin-mediated contractions of rabbit vessels. Hypertension, 19, II-87-II-93.
5. CAUVIN, C., LOUTZENHISER, R. & VAN BREEMEN, C. (1983). Mechanisms of calcium-antagonist-induced vasodilation. Annu. Rev. Pharmacol. Toxicol., 23, 373-396.
6. CHERRY, P.D., FURCHGOTT, R.F., ZAWADZKY, J.V. & JOTHIANANDAN, D. (1982). Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc. Natl. Acad. Sci. U.S.A., 79, 2106-2110.
7. 1 receptors. Eur. J. Pharmacol., 130, 11-18.
8. 1 kinin receptor-mediated vascular relaxation to contraction. Hypertension, 9, III1-III5.
9. CUTHBERT, A.W., MACVINISH, L.J. & PICKLES, R.J. (1992). Antagonism of kinin effects on epithelial by Hoe 140: apparently competitive and non-competitive interactions. Br. J. Pharmacol., 107, 797-802.
10. 9 bradykinin to relax rabbit isolated mesenteric arteries is acquired during in vitro incubation. Eur. J. Pharmacol., 142, 141-144.
11. 9-bradykinin produces tone-dependent kinin B1 receptor-mediated responses in the pulmonary vascular bed. Circ. Res., 75, 1064-1072.
12. DIXON, B.S., BRECKON, R., FORTUNE, J., VAVREK, R.J., STEWART, J.M., MARZEC-CANERT, R. & LINAS, S.L. (1990). Effects of kinins on cultured arterial smooth muscle. Am. J. Physiol., 258, C299-C308.
13. FARMER, S.G. & BURCH, R.M. (1992). Biochemical and molecular pharmacology of kinin receptors. Ann. Rev. Pharmacol. Toxicol., 32, 511-536.
14. FARMER, S.F. & BURCH, R.M. (1991). The pharmacology of bradykinin receptors. In Bradykinin Antagonists: Basic and clinical research, ed. Burch, R.M. pp. 1-31. New York: Marcel Dekker Inc.
15. 1 receptors in vivo during antigen arthritis. Agents Actions, 34, 191-193.
16. FASCIOLO, J.C., VARGAS, L., LAMA, M.C. & NOLLY, H. (1990). Bradykinin-induced contraction of rat mesenteric arteries precontracted with noradrenaline. Br. J. Pharmacol., 101, 344-348.
17. 2 receptor antagonist. Hoe 140, in isolated blood vessels from different species. Br. J. Pharmacol., 112, 683-689.
18. 2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci. Br. J. Pharmacol., 113, 607-613.
19. FOSTERMANN, V., HARTTING, G. & NEUFANG, B. (1986). The role of endothelial and non-endothelial prostaglandins in the relaxation of isolated blood vessels of the rabbit induced by acetylcholine and bradykinin. Br. J. Pharmacol., 87, 521-532.
20. 2 receptor activation on intracellular calcium, cell proliferation, and extracellular collagen secretion in mesangial cells from normal and diabetic rats. Can. J. Physiol. Pharmacol., 73, 848-853.
21. GRIDER, J., FALCONE, J., KILPATRICK, E., OTT, C. & JACKSON, B. (1995). Effect of bradykinin on NaCl transport in the medullary thick ascending limb of the rat. Eur. J. Pharmacol., 287, 101-104.
22. GROVES, P., KURZ, S., JUST, H. & DREXLER, H. (1995). Role of endogenous bradykinin in human coronary vasomotor control. Circulation, 92, 3424-3430.
23. 1 receptors and development of a cellular model for the investigation of these receptors. Br. J. Pharmacol., 109, 1254-1262.
24. LISATO, G., CUSIN, I., TIENGO, A., DEL PRATO, S. & JEANRENAUD, B. (1992). The contribution of hyperglycemia and hypoinsulinaemia to the insulin resistance of streptozotocin-induced diabetic rats. Diabetologia, 35, 310-315.
25. MARGOLIUS, H.S. (1989). Tissue kallikreins and kinins: regulation and roles in hypertensive and diabetic diseases. Annu. Rev. Pharmacol. Toxicol., 29, 343-364.
26. 2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs. Br. J. Pharmacol., 110, 71-76.
27. RAMANADHAM, S., LYNESS, W.H. & TENNER, T.E.J. (1984). Alterations in aortic and tail artery reactivity to agonists after streptozotocin treatment. Can. J. Physiol. Pharmacol., 62, 418-423.
28. 2 subtypes. Life Sci., 55, 735-749.
29. 2 receptor characterization. Trends Pharmacol. Sci., 11, 156-161.
30. REGOLI, D., MEZRAHI, J., D'ORLEANS-JUSTE, P. & CARANIKAS, S. (1982). Effect of kinins on isolated blood vessels. Role of endothelium. Can. J. Physiol. Pharmacol., 60, 1580-1583.
31. REGOLI, D. & BARABE, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1-46.
32. RHALEB, N.E., ROUISSI, N., DRAPEAU, G., JUKIC, D. & REGOLI, D. (1991). Characterization of bradykinin receptors in peripheral organs. Can. J. Physiol. Pharmacol., 69, 938-943.
33. ROSSETTI, L., SMITH, D., SHULMAN, G.I., PAPACHRISTOU, D. & DEFRONZO, R.A. (1987). Correction of hyperglycemia with phlorizin normalizes tissue sensitivity in insulin in diabetic rats. J. Clin. Invest., 79, 1510-1515.
34. TODA, N. (1977). Actions of bradykinin on isolated cerebral and peripheral arteries. Am. J. Physiol., 232, H267-H274.
35. WANG, R., WANG, Z.Z. & WU, L. (1997). Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br. J. Pharmacol., 121, 927-934.
36. WANG, R., LIU, Y., SAUVÉ, R. & ANAND-SRIVASTAVA, M.B. (1998). Diabetes-related abnormal calcium mobilization in smooth muscle cells are induced by hyperosmolality. Mol. Cell. Biochem., 183, 79-85.
37. WANG, Z.Z., MA, M. & WANG, R. (1996). Enhanced contraction of rat tail artery by toxoflavin. Br. J. Pharmacol., 117, 293-298.
38. WANG, R., PANG, P.K.T., WU, L., KAPINSKI, E., HARVEY, S. & BERDAN, R.C. (1994). Enhanced calcium influx by parathyroid hormone in identified Helisoma trivolvis snail neurons. Cell Calcium., 15, 89-96.
39. 1 kinin receptor expression and pharmacology in endothelial cells of different origins and species. J. Pharmacol. Exp. Ther., 280, 1109-1116.